Literature DB >> 21529822

Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity.

Katherine E McGoogan1, Allah B Haafiz, Regino P González Peralta.   

Abstract

OBJECTIVE: To better characterize the clinical outcomes of infants with herpes simplex virus (HSV) infection and identify useful correlates of disease severity. STUDY
DESIGN: Infants aged ≤6 months with HSV infection treated between 1999 and 2009 were identified. In patients with concurrent hepatitis, laboratory and clinical variables were examined to identify predictors of specific outcomes, including death or the need for liver transplantation and the need for intensive care.
RESULTS: Of the 15 patients enrolled, 4 (27%) had fatal disease and 2 (13%) required liver transplantation. Infants who lacked skin lesions (P = .04), had a positive HSV polymerase chain reaction result (P = .01), had more severe thrombocytopenia (P = .001), or had other organ system dysfunction (P = .002) were more likely to require intensive care. A higher International Normalized Ratio value (P = .001) and peak total bilirubin level (P = .0002) were predictive of death or the need for liver transplantation. Peak direct bilirubin level was predictive of the need for intensive care and of death or the need for liver transplantation (P = .04 and .009, respectively).
CONCLUSIONS: HSV hepatitis represents a broad spectrum of disease from mild aminotransferase elevation to fulminant liver failure and death. HSV DNA detected by polymerase chain reaction, a lack of skin lesions, and the degree of coagulopathy, thrombocytopenia, and cholestasis portend unfavorable outcomes.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529822     DOI: 10.1016/j.jpeds.2011.03.017

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Herpes Simplex Virus Infection in Infants Undergoing Meningitis Evaluation.

Authors:  Andrea T Cruz; Stephen B Freedman; Dina M Kulik; Pamela J Okada; Alesia H Fleming; Rakesh D Mistry; Joanna E Thomson; David Schnadower; Joseph L Arms; Prashant Mahajan; Aris C Garro; Christopher M Pruitt; Fran Balamuth; Neil G Uspal; Paul L Aronson; Todd W Lyons; Amy D Thompson; Sarah J Curtis; Paul T Ishimine; Suzanne M Schmidt; Stuart A Bradin; Kendra L Grether-Jones; Aaron S Miller; Jeffrey Louie; Samir S Shah; Lise E Nigrovic
Journal:  Pediatrics       Date:  2018-01-03       Impact factor: 7.124

2.  Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.

Authors:  Zachary M Parker; Tracy Jo Pasieka; George A Parker; David A Leib
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  Emergency department and inpatient clinical decision tools for the management of febrile young infants among tertiary paediatric centres across Canada.

Authors:  Brett Burstein; Jocelyn Gravel; Paul L Aronson; Mark I Neuman
Journal:  Paediatr Child Health       Date:  2018-10-05       Impact factor: 2.253

4.  Effectiveness of Early Antiviral Therapy in Disseminated Neonatal Herpes Simplex Virus 2 (HSV-2) with Fulminant Hepatic Failure.

Authors:  Divya Mirchandani; Rafia Jawed; Nayaab Khawar; Pramod Narula; Minnie John
Journal:  Am J Case Rep       Date:  2017-04-10

5.  Whole blood polymerase chain reaction in a neonate with disseminated herpes simplex virus infection and liver failure.

Authors:  Jennifer A Scoble; Mark A Underwood
Journal:  AJP Rep       Date:  2013-03-19

6.  Successful Treatment of Corticosteroid with Antiviral Therapy for a Neonatal Liver Failure with Disseminated Herpes Simplex Virus Infection.

Authors:  Shinji Maeba; Shunji Hasegawa; Maiko Shimomura; Takuya Ichimura; Kazumasa Takahashi; Masashi Motoyama; Shinnosuke Fukunaga; Yoshinori Ito; Takashi Ichiyama; Shouichi Ohga
Journal:  AJP Rep       Date:  2015-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.